The associations of nitrated polycyclic aromatic hydrocarbon exposures with plasma glucose and amino acids

Critical review on the formations and exposure of polycyclic aromatic hydrocarbons (PAHs) in the conventional hydrocarbon-based fuels: Prevention and control strategies

Polycyclic aromatic hydrocarbons (PAHs) are widely present in the atmosphere and primarily originate from the incomplete burning of fossil fuels and biofuels. Exposure to PAHs leads to harmful effects on human health and the environment. Diesel engines are a major source of PAH production in the transportation sector. Various approaches have been employed to reduce PAH emissions from diesel engines, including the use of biodiesel, green gaseous fuels, exhaust gas recirculation, exhaust after-treatment, and genetically modifying biodiesel with nanoparticles. This review focuses on PAH emissions from different generations of fuels and examines the remedial control actions taken to mitigate PAH formation. The study underscores the necessity for effective regulation of emissions from diesel engines, especially in developing countries where the reliance on fossil fuels is significant. Biodiesel has shown promise in reducing PAHs and carcinogenic pollutants, with higher biodiesel concentrations resulting in lower PAH formation. Replacing diesel with biodiesel and optimizing engine operating conditions are feasible methods to reduce PAH levels in the atmosphere. The use of nanoparticles in fuel blends and higher oxygen content in combustion chambers are also considered potential strategies for pollutant reduction. Additionally, the utilization of hydrogen and ammonia as secondary fuels has been explored as promising alternatives to fossil fuels. The study highlights the importance of further research on the presence of residual PAHs in the atmosphere and the implementation of strategies to curtail vehicular emissions.

A Systematic Review of Polycyclic Aromatic Hydrocarbon Derivatives: Occurrences, Levels, Biotransformation, Exposure Biomarkers, and Toxicity

Polycyclic aromatic hydrocarbon (PAH) derivatives constitute a significant class of emerging contaminants that have been ubiquitously detected in diverse environmental matrixes, with some even exhibiting higher toxicities than their corresponding parent PAHs. To date, compared with parent PAHs, fewer systematic summaries and reanalyses are available for PAH derivatives with great environmental concerns. This review summarizes the current knowledge on the chemical species, levels, biotransformation patterns, chemical analytical methods, internal exposure routes with representative biomarkers, and toxicity of PAH derivatives, primarily focusing on nitrated PAHs (NPAHs), oxygenated PAHs (OPAHs), halogenated PAHs (XPAHs), and alkylated PAHs (APAHs). A collection of 188 compounds from four categories, 44 NPAHs, 36 OPAHs, 56 APAHs, and 52 XPAHs, has been compiled from 114 studies that documented the environmental presence of PAH derivatives. These compounds exhibited weighted average air concentrations that varied from a lower limit of 0.019 pg/m3 to a higher threshold of 4060 pg/m3. Different analytical methods utilizing comprehensive two-dimensional gas chromatography coupled with high-resolution time-of-flight mass spectrometry (GC × GC-TOF-MS), gas chromatography coupled to time-of-flight mass spectrometry (GC-TOF-MS), comprehensive two-dimensional gas chromatography coupled to quadrupole mass spectrometry (GC × GC-QQQ-MS), and Fourier-transform ion cyclotron resonance mass spectrometry (FT-ICR MS), that adopted untargeted strategies for the identification of PAH derivatives are also reviewed here. Additionally, an in-depth analysis of biotransformation patterns for each category is provided, including the likelihood of specific biotransformation reaction types. For the toxicity, we primarily summarized key metabolic activation pathways, which could result in the formation of reactive metabolites capable of covalently bonding with DNA and tissue proteins, and potential health outcomes such as carcinogenicity and genotoxicity, oxidative stress, inflammation and immunotoxicity, and developmental toxicity that might be mediated by the aryl hydrocarbon receptor (AhR). Finally, we pinpoint research challenges and emphasize the need for further studies on identifying PAH derivatives, tracking external exposure levels, evaluating internal exposure levels and associated toxicity, clarifying exposure routes, and considering mixture exposure effects. This review aims to provide a broad understanding of PAH derivatives' identification, environmental occurrence, human exposure, biotransformation, and toxicity, offering a valuable reference for guiding future research in this underexplored area.

Oral cavity response to air pollutant exposure and association with pulmonary inflammation and symptoms in asthmatic children

Exposure to fine particulate matter (PM_2.5) and ozone (O₃) may lead to inflammation and oxidative damage in the oral cavity, which is hypothesized to contribute to the worsening of airway inflammation and asthma symptoms. In this panel study of 43 asthmatic children aged 5-13 years old, each child had 4 clinic visits with a 2-week interval between two consecutive visits. At each visit, saliva samples were collected and subsequently analyzed for interleukin 6 (IL-6) and eosinophil cationic protein (ECP) as biomarkers of inflammation and malondialdehyde (MDA) as a biomarker of oxidative stress in the oral cavity. At each visit, children were measured for fractional exhaled nitric oxide (FeNO) as a marker of pulmonary inflammation. Asthma symptoms of these children were measured using the Childhood Asthma Control Test (C-ACT). We found that an interquartile range (IQR) increase in 24-h average personal exposure to PM_2.5 measured 1 and 2 days prior was associated with increased salivary IL-6 concentration by 3.0% (95%CI: 0.2%-6.0%) and 4.2% (0.7%-8.0%), respectively. However, we did not find a clear association between personal O₃ exposure and any of the salivary biomarkers, except for a negative association between salivary MDA and O₃ exposure measured 1 day prior. An IQR increase in salivary IL-6 concentration was associated with significantly increased FeNO by 28.8% (4.3%-53.4%). In addition, we found that increasing salivary IL-6 concentrations were associated with decreased individual and total C-ACT scores, indicating the worsening of asthma symptoms. We estimated that 13.2%-22.2% of the associations of PM_2.5 exposure measured 1 day prior with FeNO and C-ACT scores were mediated by salivary IL-6. These findings suggest that the induction of inflammation in the oral cavity may have played a role in linking air pollution exposure with the worsening of airway inflammation and asthma symptoms.